Early Screening for Diagnostics
Made Accessible
Consumers
With its non-intrusive and portable design we offer individuals the potential for early disease screening in the comfort of their homes, providing a cost-effective complement to traditional diagnostics.
Insurance Providers
We could assist in streamlining risk assessments by providing early health indicators through screening, supporting more accurate policy decisions and reducing potential underwriting costs.
Healthcare Professionals
Early screening may aid in identifying diseases such as lung and breast cancer, offering a supportive tool for improving diagnostic accuracy and patient care outcomes.
Reach out to us for more information.
Undergoing Clinical Testing
DrNose is currently undergoing rigorous testing in collaboration with prestigious universities and a team of experts in medicine, electronics, and AI.
Lung Cancer
Initial trials at University of New South Wales show a 90% specificity.
Breast cancer
Initial trials at Ben Gurion University, Israel show a 95% accuracy.
colorectal cancer
Coming soon.
prostate cancer
Coming soon.
stomach cancer
Coming soon.
diabetes
Coming soon.
copd
Coming soon.
ashtma
Coming soon.
gastrointestinal disorders
Coming soon.